The American Secretary of Health and Social Services (HHS), Robert F. Kennedy Jr. and the Secretary of Education, Linda McMahon, attend a Make America Healthy Again (Maha) event, in the East House House in Washington, DC, United States, May 22, 2025.
Evelyn Hockstein | Reuters
A group of key and reworked vaccination advisers appointed by the Secretary of Health and Social Services Robert F. Kennedy Jr. will soon vote on a penalty of fire which contains Mercury, which is used safely in certain flu blows but has been poorly linked to autism in the past.
The advisory committee for vaccination practices, or ACIP, will hear a presentation on the curator, called Thimérosal, during a meeting scheduled for June 26. The Committee will also vote on “the recommendations of the vaccine containing Thimérosal”, according to a two -day meeting project published on Wednesday.
This is the first panel meeting with new members of Kennedy, many of whom are well -known vaccine reviews. He appointed the eight advisers last week after having dismissed the 17 previous members of the Committee, which advises the Centers for Disease Control and Prevention on vaccine policy.
We do not know what will be discussed in the presentation or what the panel will vote exactly.
Thimérosal has been widely used for decades as a preservative to prevent the growth of harmful bacteria in several drugs and vaccines in multiple doses. But its use in approved vaccines has dropped sharply because the manufacturers have moved to single dose packaging for their shots, which do not require preservatives.
Some multi-dose forms of influenza vaccines for adults always contain Thimérosal, including SanofiFluzone and two shots from the Biotechnology Society CSL Seqirus. According to the Food and Drug Administration, all vaccines are systematically recommended for children aged 6 and under in the United States.
The FDA and other health organizations have stressed that numerous well -conducted scientific studies have found no link between Thimérosal and Autism, despite unfounded concerns decades concerning a potential connection.
“The scientific evidence collected in the past 20 years has not showed any evidence of prejudice, including serious neurodevelopmental disorders, the use of Thimérosal in vaccines,” said FDA on its website.
The new members of the AIPI will play an important role in the development of the immunization policy in the United States, because the panel examines the data from the vaccines and makes recommendations which determine which is eligible for fire and if insurers should cover them, among other efforts. The Committee should also examine the data and vote on other vaccines, including shots for COVID and RSV at the two -day meeting.